mRNA |
GDC-0941 |
CTRPv2 |
pan-cancer |
AAC |
-0.027 |
0.5 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.027 |
0.5 |
mRNA |
Doxorubicin |
gCSI |
pan-cancer |
AAC |
-0.037 |
0.5 |
mRNA |
BRD-K29086754 |
CTRPv2 |
pan-cancer |
AAC |
0.055 |
0.5 |
mRNA |
GW-405833 |
CTRPv2 |
pan-cancer |
AAC |
0.025 |
0.5 |
mRNA |
FK866 |
CTRPv2 |
pan-cancer |
AAC |
-0.028 |
0.5 |
mRNA |
ibrutinib |
CTRPv2 |
pan-cancer |
AAC |
-0.03 |
0.5 |
mRNA |
PF-4800567 hydrochloride |
CTRPv2 |
pan-cancer |
AAC |
-0.039 |
0.5 |
mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.027 |
0.5 |
mRNA |
MGCD-265 |
CTRPv2 |
pan-cancer |
AAC |
-0.025 |
0.5 |